Search Results - "Majmudar, Parag A."

Refine Results
  1. 1

    Enhancing DMEK Success by Identifying Optimal Levels of Trypan Blue Dye Application to Donor Corneal Tissue by Majmudar, Parag A, Johnson, Lauren

    Published in Cornea (01-02-2017)
    “…PURPOSE:The purpose of this study was to determine the correct concentration and duration of application of trypan blue dye to Descemet membrane endothelial…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Transepithelial crosslinking retreatment of progressive corneal ectasia unresponsive to classic crosslinking by Rubinfeld, Roy S., MD, Epstein, Rachel H., MD, Majmudar, Parag A., MD, Kim, Deborah, OD, Choi, Michael, BS, Epstein, Randy J., MD

    “…A 41-year-old man presented 10 years after uneventful laser in situ keratomileusis (LASIK) with symptomatic post-LASIK ectasia. He had treatment with the…”
    Get full text
    Journal Article
  4. 4

    Late-onset fungal interface keratitis following endothelial keratoplasty with positive donor fungal culture by Beckman, Kenneth A., Milner, Mark S., Majmudar, Parag A., Luchs, Jodi I.

    “…To describe late-onset fungal keratitis after Descemet's stripping endothelial keratoplasty (DSEK) with positive fungal culture of the donor corneal rim. A…”
    Get full text
    Journal Article
  5. 5

    Reduced Application Time for Prophylactic Mitomycin C in Photorefractive Keratectomy by Virasch, Vanee V., MD, Majmudar, Parag A., MD, Epstein, Randy J., MD, Vaidya, Neel S, Dennis, Richard F., MD

    Published in Ophthalmology (Rochester, Minn.) (01-05-2010)
    “…Objective To determine whether the duration of mitomycin C (MMC) 0.02% application affects visual outcome or the incidence of subepithelial haze in patients…”
    Get full text
    Journal Article
  6. 6

    A Randomized Clinical Study (SEECASE) to Assess Efficacy, Safety, and Tolerability of NOV03 for Treatment of Dry Eye Disease by Tauber, Joseph, Wirta, David L., Sall, Kenneth, Majmudar, Parag A., Willen, Daniela, Krösser, Sonja

    Published in Cornea (01-09-2021)
    “…NOV03 has a unique dual mode of action to address dry eye disease (DED) associated with meibomian gland dysfunction. SEECASE evaluated the efficacy, safety,…”
    Get full text
    Journal Article
  7. 7

    Enhancing DMEK Success by Identifying Optimal Levels of Trypan Blue Dye Application to Donor Corneal Tissue by Majmudar, Parag A, Johnson, Lauren

    Published in Cornea (01-02-2017)
    “…The purpose of this study was to determine the correct concentration and duration of application of trypan blue dye to Descemet membrane endothelial…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Prevalence of SARS-CoV-2 in human post-mortem ocular tissues by Sawant, Onkar B., Singh, Sneha, Wright, Robert Emery, Jones, Kayla M., Titus, Michael S., Dennis, Eugene, Hicks, Eric, Majmudar, Parag A., Kumar, Ashok, Mian, Shahzad I.

    Published in The ocular surface (01-01-2021)
    “…SARS-CoV-2 is found in conjunctival swabs and tears of COVID-19 patients. However, the presence of SARS-CoV-2 has not been detected in the human eye to date…”
    Get full text
    Journal Article
  10. 10

    Fungal Infectious Interface Keratitis Presenting 2 Years After Descemet Membrane Endothelial Keratoplasty by Vaidya, Neel S., Epstein, Rachel H., Majmudar, Parag A.

    Published in Cornea (01-07-2022)
    “…Purpose: The purpose of this study was to describe infectious interface keratitis after Descemet membrane endothelial keratoplasty (DMEK) more than 2 years…”
    Get full text
    Journal Article
  11. 11

    Safety of Lifitegrast Ophthalmic Solution 5.0% in Patients With Dry Eye Disease: A 1-Year, Multicenter, Randomized, Placebo-Controlled Study by Donnenfeld, Eric D, Karpecki, Paul M, Majmudar, Parag A, Nichols, Kelly K, Raychaudhuri, Aparna, Roy, Monica, Semba, Charles P

    Published in Cornea (01-06-2016)
    “…PURPOSE:To evaluate the 1-year safety of lifitegrast ophthalmic solution 5.0% in patients with dry eye disease compared with placebo. METHODS:SONATA (Safety Of…”
    Get full text
    Journal Article
  12. 12

    Adjuvant Stromal Amphotericin B Injection for Late-Onset DMEK Infection by Tu, Elmer Y, Majmudar, Parag A

    Published in Cornea (01-12-2017)
    “…PURPOSE:To report the successful medical management of a late-onset Descemet membrane endothelial keratoplasty (DMEK)-related interface infection. METHODS:A…”
    Get full text
    Journal Article
  13. 13

    Phakic Intraocular Lens Implantation for the Correction of Myopia: A Report by the American Academy of Ophthalmology by HUANG, David, SCHALLHORN, Steven C, SUGAR, Alan, FARJO, Ayad A, MAJMUDAR, Parag A, TRATTLER, William B, TANZER, David J

    Published in Ophthalmology (Rochester, Minn.) (01-11-2009)
    “…To review the published literature for evaluation of the safety and outcomes of phakic intraocular lens (pIOL) implantation for the correction of myopia and…”
    Get full text
    Journal Article
  14. 14

    Impact of the COVID-19 Pandemic on Keratoplasty and Corneal Eye Banking by Ballouz, Dena, Sawant, Onkar B., Hurlbert, Susan, Titus, Michael S., Majmudar, Parag A., Kumar, Ashok, Zhou, Yunshu, Musch, David C., Mian, Shahzad I.

    Published in Cornea (01-08-2021)
    “…Purpose: The purpose of this study was to assess the impact of COVID-19 guidelines for corneal donor tissue screening and the utility of routine postmortem…”
    Get full text
    Journal Article
  15. 15

    Femtosecond lasers for LASIK flap creation: a report by the American Academy of Ophthalmology by Farjo, Ayad A, Sugar, Alan, Schallhorn, Steven C, Majmudar, Parag A, Tanzer, David J, Trattler, William B, Cason, John B, Donaldson, Kendall E, Kymionis, George D

    Published in Ophthalmology (Rochester, Minn.) (01-03-2013)
    “…To review the published literature to assess the safety, efficacy, and predictability of femtosecond lasers for the creation of corneal flaps for LASIK; to…”
    Get full text
    Journal Article
  16. 16
  17. 17

    COVID-19 and Eye Banking: Ongoing Impacts of the Pandemic by Ballouz, Dena, Issa, Rafik, Sawant, Onkar B., Hurlbert, Susan, Titus, Michael S., Zhou, Yunshu, Musch, David C., Majmudar, Parag A., Kumar, Ashok, Mian, Shahzad I.

    Published in Cornea (01-01-2023)
    “…Purpose: The purpose of this study was to assess the impact of ongoing waves of the COVID-19 pandemic and resulting guidelines on the corneal donor pool with…”
    Get full text
    Journal Article
  18. 18

    Mitomycin-C in corneal surface excimer laser ablation techniques: a report by the American Academy of Ophthalmology by Majmudar, Parag A, Schallhorn, Steven C, Cason, John B, Donaldson, Kendall E, Kymionis, George D, Shtein, Roni M, Verity, Steven M, Farjo, Ayad A

    Published in Ophthalmology (Rochester, Minn.) (01-06-2015)
    “…To review the published literature assessing the efficacy and safety of mitomycin-C (MMC) as an adjunctive treatment in corneal surface excimer laser ablation…”
    Get full text
    Journal Article
  19. 19

    The Prospective Health Assessment of Cataract Patients' Ocular Surface (PHACO) study: the effect of dry eye by Trattler, William B, Majmudar, Parag A, Donnenfeld, Eric D, McDonald, Marguerite B, Stonecipher, Karl G, Goldberg, Damien F

    Published in Clinical ophthalmology (Auckland, N.Z.) (01-01-2017)
    “…To determine the incidence and severity of dry eye as determined by the International Task Force (ITF) scale in patients being screened for cataract surgery…”
    Get full text
    Journal Article
  20. 20

    Mitomycin-C in Corneal Surface Excimer Laser Ablation Techniques by Majmudar, Parag A., MD, Schallhorn, Steven C., MD, Cason, John B., MD, Donaldson, Kendall E., MD, MS, Kymionis, George D., MD, PhD, Shtein, Roni M., MD, Verity, Steven M., MD, Farjo, Ayad A., MD

    Published in Ophthalmology (Rochester, Minn.) (01-06-2015)
    “…Objective To review the published literature assessing the efficacy and safety of mitomycin-C (MMC) as an adjunctive treatment in corneal surface excimer laser…”
    Get full text
    Journal Article